2018
DOI: 10.1007/s11764-018-0720-x
|View full text |Cite
|
Sign up to set email alerts
|

Correlates of smoking status in cancer survivors

Abstract: Purpose: To determine the characteristics associated with cancer survivors which indicate continued cigarette smoking at or around the time of cancer diagnosis. Methods: 631 survivors were recruited in four cancer centers in Memphis, TN, between March 2015 and June 2016. To increase the probability of accurate reporting, surveys were conducted anonymously. 112 respondents reported they were current smokers and 202 reported they were former smokers (n=314), who comprised the sample. Results: We found that t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 34 publications
4
6
0
Order By: Relevance
“…Therefore, the last two columns provide results from a partial proportional odds model where the proportional odds assumptions held for race and ethnicity and relationship status, but not for clinic, sex, insurance status, age tertiles, and distress tertiles. tobacco treatment, study results point toward a focus on patients with cancer who are male, are not in a relationship, have Medicaid insurance, and report high distress, consistent with previous studies on correlates of smoking in patients with cancer 7,46,47 ; the results for disease site or clinic were mixed, so firm conclusions are untenable.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…Therefore, the last two columns provide results from a partial proportional odds model where the proportional odds assumptions held for race and ethnicity and relationship status, but not for clinic, sex, insurance status, age tertiles, and distress tertiles. tobacco treatment, study results point toward a focus on patients with cancer who are male, are not in a relationship, have Medicaid insurance, and report high distress, consistent with previous studies on correlates of smoking in patients with cancer 7,46,47 ; the results for disease site or clinic were mixed, so firm conclusions are untenable.…”
Section: Discussionsupporting
confidence: 81%
“… 17 , 31 There might even be sufficient reason to extend core items of the Cancer Patient Tobacco Use Questionnaire to include questions about noncigarette tobacco use 13 , 17 and to extend eligibility for clinical trials and treatment programs to all patients with cancer who use tobacco, not just those who smoke cigarettes. 43 - 45 In trying to reach the target audience for tobacco treatment, study results point toward a focus on patients with cancer who are male, are not in a relationship, have Medicaid insurance, and report high distress, consistent with previous studies on correlates of smoking in patients with cancer 7 , 46 , 47 ; the results for disease site or clinic were mixed, so firm conclusions are untenable.…”
Section: Discussionsupporting
confidence: 76%
“…Choi and Forster 79 Biener and Hargraves 23 ; daily EC use Giovenco and Delnevo 13 ; prior but no current EC use Kalkhoran et al 49 ; less than daily EC use Little et al 54 Subtotal (I 2 = 76.3%; P < .001) Subtotal (I 2 = 97.5%; P < .001)…”
Section: Imprecision No Serious Imprecisionmentioning
confidence: 99%
“…This study did not ascertain the reason for noncigarette tobacco use, but one could surmise that it is due to the belief these products might aid smoking cessation or be a helpful substitute in places or during times when smoking is prohibited (Popova & Ling, 2013; Shi et al, 2017). Reports of electronic cigarette use in cancer survivors have grown in recent years (Akinboro et al, 2019; Kalkhoran et al, 2018), though research on other products remains rare (see Little et al, 2018 for an exception). Importantly, trial and adoption of electronic cigarettes and the like among cancer survivors who smoke may outpace the rate at which we accumulate empirical evidence of their safety profile and effectiveness for smoking cessation (Kalkhoran & Glantz, 2016; McRobbie et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…It is possible that correlates for CCS’ smoking behavior are largely consistent with what is found in other cancer survivor samples. If that literature is applied to CCS, younger age, lower socioeconomic status, lower levels of education, White race, and less healthcare access would be risk factors; stronger cancer-related risk perceptions, motivation to quit, and self-efficacy to quit would be protective factors; and gender, ethnicity, cancer stage, cancer treatment, time since cancer diagnosis, and emotional problems would show weak or inconsistent relationships (Little et al, 2018; Mayer & Carlson, 2011; Swoboda et al, 2019; Tseng et al, 2010; Waggoner et al, 2010).…”
mentioning
confidence: 99%